Stefanie Mullins

2.5k total citations
18 papers, 1.3k citations indexed

About

Stefanie Mullins is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Stefanie Mullins has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Stefanie Mullins's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Stefanie Mullins is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (5 papers) and Protease and Inhibitor Mechanisms (5 papers). Stefanie Mullins collaborates with scholars based in United States, United Kingdom and Australia. Stefanie Mullins's co-authors include Jonathan D. Cheng, Bonnie F. Sloane, Galia Blum, Matthew Bogyo, Christopher Jedeszko, Hyung‐Ok Lee, Matthildi Valianou, Edna Cukierman, Janusz Franco‐Barraza and Mark J. Rice and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Stefanie Mullins

17 papers receiving 1.3k citations

Peers

Countries citing papers authored by Stefanie Mullins

Since Specialization

Citations

This map shows the geographic impact of Stefanie Mullins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Mullins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Mullins more than expected).

Fields of papers citing papers by Stefanie Mullins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Mullins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Mullins. The network helps show where Stefanie Mullins may publish in the future.

Co-authorship network of co-authors of Stefanie Mullins

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Mullins. A scholar is included among the top collaborators of Stefanie Mullins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Mullins. Stefanie Mullins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Title	Journal	Authors	Indexed citations
1	Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer	Clinical & Translational Immunology	Damien Zanker, Alex Spurling et al.	30
2	Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies	Journal for ImmunoTherapy of Cancer	Stefanie Mullins, John P. Vasilakos et al.	137
3	Abstract 711: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies	Cancer Research	Stefanie Mullins, John P. Vasilakos et al.	1
4	Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent	Clinical Cancer Research	Bangwen Xie, Michal R. Tomaszewski et al.	24
5	The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment	Journal for ImmunoTherapy of Cancer	Edmund Poon, Stefanie Mullins et al.	59
6	Abstract 4697: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment and holds potential for combination with immune checkpoint inhibitors	Cancer Research	Stefanie Mullins, Katharina Vogel et al.	1
7	Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model	Oncotarget	Nadia Luheshi, James A. Harper et al.	67
8	Immune mediated therapy and MEK inhibition: preclinical assessment of immunobiology and combination activity in vitro and in vivo	Journal for ImmunoTherapy of Cancer	Ross Stewart, Edmund Poon et al.	0
9	Preclinical modelling of immune checkpoint blockade (P2012)	The Journal of Immunology	Ross Stewart, Stefanie Mullins et al.	6
10	Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins	Biological Chemistry	Stefanie Mullins, Mansoureh Sameni et al.	27
11	Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens	The FASEB Journal	Jiping Zhang, Matthildi Valianou et al.	15
12	FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells	BMC Cancer	Hyung‐Ok Lee, Stefanie Mullins et al.	243
13	Microarrays for Protease Detection in Tissues and Cells	Methods in molecular biology	Kamiar Moin, Donald R. Schwartz et al.	2
14	Imaging and quantifying the dynamics of tumor-associated proteolysis	Clinical & Experimental Metastasis	Mansoureh Sameni, Dora Cavallo‐Medved et al.	37
15	p21-Activated Kinase 1 Coordinates Aberrant Cell Survival and Pericellular Proteolysis in a Three-Dimensional Culture Model for Premalignant Progression of Human Breast Cancer	Neoplasia	Quan-Wen Li, Stefanie Mullins et al.	73
16	Photodynamic Molecular Beacon Triggered by Fibroblast Activation Protein on Cancer-Associated Fibroblasts for Diagnosis and Treatment of Epithelial Cancers	Journal of Medicinal Chemistry	Pui‐Chi Lo, Juan Chen et al.	86
17	Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer	Cancer Biology & Therapy	Kalyani Narra, Stefanie Mullins et al.	208
18	Dynamic imaging of protease activity with fluorescently quenched activity-based probes	Nature Chemical Biology	Galia Blum, Stefanie Mullins et al.	310

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact